(Q40300682)

19 September 2017

1 reference

title

Psoriasis: current advances in etiology and treatment (English)

1 reference

19 September 2017

Cram DL

1

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 January 1981

1 reference

Journal of the American Academy of Dermatology

19 September 2017

published in

1 reference

19 September 2017

volume

4

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

1-14

1 reference

Ultrastructure of the human dermal microcirculation. II. The capillary loops of the dermal papillae

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Abnormal cell proliferation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

The cell cycle in psoriasis: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

HEREDITY AND PSORIASIS. STUDY OF A LARGE FAMILY.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Histocompatibility (HL-A) Antigens Associated with Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

HLA C and D antigens associated with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Psoriasis in an Unselected Series of Twins

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Natural history of psoriasis in 61 twin pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Molecular Mechanisms In Proliferative Skin Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Prostaglandins and cyclic AMP in epidermis. Evidence for the independent action of prostaglandins and adrenaline on the adenyl cyclase system of pig and human epidermis, normal and psoriatic

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Glucocorticoid inhibits elevated polyamine biosynthesis in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Cellular serine proteinase induces chemotaxis by complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Monocyte Function in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Inflammatory and immune cell function in psoriasis: II. Monocyte function, lymphokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Increased granulocyte adherence in psoriasis and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Leukotactic properties of soluble substances in psoriasis scale

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Chemokinetic and chemotactic factors in psoriasis scale extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Immunological aspects of psoriasis. I. Immunoglobulins and anti-IgG factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

IgG antiglobulin levels in patients with psoriatic arthropathy, ankylosing spondylitis, and gout

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Clinical aspects of T and B lymphocytes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Evaluation of lymphocyte subpopulations and T-cell functions in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

New concepts in the pathogenesis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Lymphocyte activation by streptococcal antigens in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Crude Coal Tar Plus Near Ultraviolet Light Suppresses DNA Synthesis in Epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Updating the Goeckerman regimen for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

1 reference

7 January 2021

Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Hospital treatment of psoriasis. A modified anthralin program

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

A Topical Treatment Program for Psoriasis with Low Anthralin Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

GENERALIZED PUSTULAR PSORIASIS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Retinoids in dermatology: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

1 reference

7 January 2021

Use of methotrexate in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Effects of methotrexate on the liver in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Methotrexate pneumonitis in a psoriatic

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Progressive interstitial lung disease from prolonged methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Renal toxicity of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Psoriasis, methotrexate, and oligospermia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Dialysis Therapy for Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Hemodialysis in the treatment of psoriasis. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Peritoneal dialysis for psoriasis. An uncontrolled study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Psoriasis Developing De Novo During Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Effect of 8-Methoxypsoralen Plus UVA on Psoriasis Leukotactic Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Photochemotherapy for pustular psoriasis (von Zumbusch).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Augmentation of Oral Methoxsalen-Photochemotherapy with an Oral Retinoic Acid Derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Melanocyte changes following PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Colloid-amyloid Bodies in PUVA-treated Human Psoriatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Potential ocular complications from PUVA therapy and their prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

Current status of oral PUVA therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2881%2970001-X

7 January 2021

10.1016/S0190-9622(81)70001-X

Identifiers

DOI

1 reference

19 September 2017

1 reference